Improving Patients' Adherence to Their Chronic Treatments by Implementing a Simple, Standardized and Redundant Message Delivered by Healthcare Professionals: a Stepped-wedge Multicenter Randomized Trial
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Chronic Disease
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 1210
- Locations
- 10
- Primary Endpoint
- Improvement in therapeutic adherence
- Status
- Not Yet Recruiting
- Last Updated
- last year
Overview
Brief Summary
The primary objective in this study is to achieve a 15% 6-month improvement in therapeutic adherence among patients with chronic pathologies, thanks to a simple, standardized and redundant message delivered by healthcare professionals during consultations/interviews Trained healthcare professionals deliver a simple, standardized and redundant 3-point message to patients, based on the levers of action concerning therapeutic adherence. This message is delivered with the aim of modifying the patient's behavior with regard to treatment intake.
Detailed Description
This project will enable us to adapt or even modify the practices of healthcare professionals, by making management recommendations to improve patients' adherence to treatment during their consultations/interviews, and throughout their entire course of care. This project will increase the benefit/risk ratio of treatments and reduce the waste of healthcare resources. For patients, their participation by filling in the therapeutic adherence self-questionnaire will enable them to become active players in the management of their treatment. If the results of our study prove positive, this will lead to a new, optimized organization of patient care.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult patients (age ≥ 18 years)
- •Affiliated to the French social security system
- •Followed in hospital for a chronic pathology within a formalized care pathway
- •Having signed a consent form to participate in the study.
Exclusion Criteria
- •Patients included in the control period.
- •Patients under guardianship.
- •Pregnant or breast-feeding patients.
- •Patients taking part in research on compliance
Outcomes
Primary Outcomes
Improvement in therapeutic adherence
Time Frame: 6 months
The medication possession ratio (MPR), calculated as the ratio between the sum of treatment days delivered over the period of interest x 100, expressed as a %. In the literature, an MPR ≥ 80% corresponds to good therapeutic adherence.
Secondary Outcomes
- Improvement in therapeutic adherence(12 months)
- Predictive factors of improved adherence factors predictive of therapeutic adherence(6 months)
- Improvement in therapeutic adherence estimated(12 months)
- Costs of care according to periods (control vs. intervention)(12 months)
- Cost of the intervention(12 months)
- Satisfaction of participating healthcare professionals and reasons for refusal to participate(12 months)